vs
Side-by-side financial comparison of Citi Trends Inc (CTRN) and Varex Imaging Corp (VREX). Click either name above to swap in a different company.
Varex Imaging Corp is the larger business by last-quarter revenue ($209.6M vs $197.1M, roughly 1.1× Citi Trends Inc). Varex Imaging Corp runs the higher net margin — 1.1% vs -3.5%, a 4.6% gap on every dollar of revenue. On growth, Citi Trends Inc posted the faster year-over-year revenue change (10.1% vs 4.9%). Citi Trends Inc produced more free cash flow last quarter ($767.0K vs $-26.8M). Over the past eight quarters, Varex Imaging Corp's revenue compounded faster (0.8% CAGR vs -4.3%).
Citi Trends, Inc. is an American retail clothing chain selling discounted products targeted primarily at African-American customers.
Varex Imaging Corp is a global supplier of advanced imaging components and solutions, including X-ray tubes, digital flat panel detectors, and image processing software. Its products serve medical imaging, radiation oncology, and industrial non-destructive testing segments, with customers across key global markets.
CTRN vs VREX — Head-to-Head
Income Statement — Q3 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $197.1M | $209.6M |
| Net Profit | $-6.9M | $2.3M |
| Gross Margin | — | 33.3% |
| Operating Margin | -3.7% | 7.3% |
| Net Margin | -3.5% | 1.1% |
| Revenue YoY | 10.1% | 4.9% |
| Net Profit YoY | 3.6% | 866.7% |
| EPS (diluted) | $-0.86 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $209.6M | ||
| Q4 25 | $197.1M | $228.9M | ||
| Q3 25 | $190.8M | $203.0M | ||
| Q2 25 | $201.7M | $212.9M | ||
| Q1 25 | $211.2M | $199.8M | ||
| Q4 24 | $179.1M | — | ||
| Q3 24 | $176.6M | $205.7M | ||
| Q2 24 | $186.3M | $209.1M |
| Q1 26 | — | $2.3M | ||
| Q4 25 | $-6.9M | $12.2M | ||
| Q3 25 | $3.8M | $-89.1M | ||
| Q2 25 | $871.0K | $6.9M | ||
| Q1 25 | $-14.2M | $-300.0K | ||
| Q4 24 | $-7.2M | — | ||
| Q3 24 | $-18.4M | $-51.1M | ||
| Q2 24 | $-3.4M | $1.4M |
| Q1 26 | — | 33.3% | ||
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 33.3% | ||
| Q2 25 | — | 36.0% | ||
| Q1 25 | — | 34.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 32.6% | ||
| Q2 24 | — | 32.0% |
| Q1 26 | — | 7.3% | ||
| Q4 25 | -3.7% | 8.6% | ||
| Q3 25 | 1.8% | -39.8% | ||
| Q2 25 | 0.2% | 10.4% | ||
| Q1 25 | 0.6% | 5.6% | ||
| Q4 24 | -4.9% | — | ||
| Q3 24 | -14.1% | 5.3% | ||
| Q2 24 | -3.7% | 4.4% |
| Q1 26 | — | 1.1% | ||
| Q4 25 | -3.5% | 5.3% | ||
| Q3 25 | 2.0% | -43.9% | ||
| Q2 25 | 0.4% | 3.2% | ||
| Q1 25 | -6.7% | -0.2% | ||
| Q4 24 | -4.0% | — | ||
| Q3 24 | -10.4% | -24.8% | ||
| Q2 24 | -1.8% | 0.7% |
| Q1 26 | — | $0.05 | ||
| Q4 25 | $-0.86 | $0.29 | ||
| Q3 25 | $0.46 | $-2.15 | ||
| Q2 25 | $0.11 | $0.17 | ||
| Q1 25 | $-1.70 | $-0.01 | ||
| Q4 24 | $-0.86 | — | ||
| Q3 24 | $-2.21 | $-1.25 | ||
| Q2 24 | $-0.42 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $125.6M |
| Total DebtLower is stronger | — | $367.6M |
| Stockholders' EquityBook value | $107.8M | $476.9M |
| Total Assets | $464.3M | $1.1B |
| Debt / EquityLower = less leverage | — | 0.77× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $125.6M | ||
| Q4 25 | — | $155.1M | ||
| Q3 25 | — | $152.6M | ||
| Q2 25 | — | $223.0M | ||
| Q1 25 | — | $212.6M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $200.5M | ||
| Q2 24 | — | $190.0M |
| Q1 26 | — | $367.6M | ||
| Q4 25 | — | $367.5M | ||
| Q3 25 | — | $367.5M | ||
| Q2 25 | — | $567.2M | ||
| Q1 25 | — | $567.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $443.4M | ||
| Q2 24 | — | $443.1M |
| Q1 26 | — | $476.9M | ||
| Q4 25 | $107.8M | $472.6M | ||
| Q3 25 | $113.2M | $455.3M | ||
| Q2 25 | $108.6M | $549.7M | ||
| Q1 25 | $113.2M | $540.2M | ||
| Q4 24 | $130.3M | — | ||
| Q3 24 | $136.6M | $529.1M | ||
| Q2 24 | $154.8M | $581.2M |
| Q1 26 | — | $1.1B | ||
| Q4 25 | $464.3M | $1.1B | ||
| Q3 25 | $457.4M | $1.1B | ||
| Q2 25 | $437.4M | $1.4B | ||
| Q1 25 | $462.8M | $1.3B | ||
| Q4 24 | $467.1M | — | ||
| Q3 24 | $506.7M | $1.2B | ||
| Q2 24 | $484.1M | $1.3B |
| Q1 26 | — | 0.77× | ||
| Q4 25 | — | 0.78× | ||
| Q3 25 | — | 0.81× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.6M | $-16.1M |
| Free Cash FlowOCF − Capex | $767.0K | $-26.8M |
| FCF MarginFCF / Revenue | 0.4% | -12.8% |
| Capex IntensityCapex / Revenue | 4.0% | 5.1% |
| Cash ConversionOCF / Net Profit | — | -7.00× |
| TTM Free Cash FlowTrailing 4 quarters | $11.9M | $-13.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-16.1M | ||
| Q4 25 | $8.6M | $7.9M | ||
| Q3 25 | $3.9M | $7.7M | ||
| Q2 25 | $-11.0M | $16.6M | ||
| Q1 25 | $28.5M | $9.5M | ||
| Q4 24 | $-18.4M | — | ||
| Q3 24 | $5.6M | $25.9M | ||
| Q2 24 | $-19.6M | $8.0M |
| Q1 26 | — | $-26.8M | ||
| Q4 25 | $767.0K | $2.3M | ||
| Q3 25 | $-1.7M | $1.4M | ||
| Q2 25 | $-13.1M | $9.8M | ||
| Q1 25 | $26.0M | $5.3M | ||
| Q4 24 | $-20.4M | — | ||
| Q3 24 | $1.7M | $19.9M | ||
| Q2 24 | $-21.2M | $3.3M |
| Q1 26 | — | -12.8% | ||
| Q4 25 | 0.4% | 1.0% | ||
| Q3 25 | -0.9% | 0.7% | ||
| Q2 25 | -6.5% | 4.6% | ||
| Q1 25 | 12.3% | 2.7% | ||
| Q4 24 | -11.4% | — | ||
| Q3 24 | 0.9% | 9.7% | ||
| Q2 24 | -11.4% | 1.6% |
| Q1 26 | — | 5.1% | ||
| Q4 25 | 4.0% | 2.4% | ||
| Q3 25 | 2.9% | 3.1% | ||
| Q2 25 | 1.0% | 3.2% | ||
| Q1 25 | 1.2% | 2.1% | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 2.2% | 2.9% | ||
| Q2 24 | 0.9% | 2.2% |
| Q1 26 | — | -7.00× | ||
| Q4 25 | — | 0.65× | ||
| Q3 25 | 1.01× | — | ||
| Q2 25 | -12.59× | 2.41× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTRN
Segment breakdown not available.
VREX
| Medical Segment | $144.8M | 69% |
| Industrial Segment | $64.8M | 31% |
